Seeking Alpha

QualityStocks'  Instablog

Send Message
QualityStocks ( assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • Biozoom, Inc. (BIZM) Reaches Milestone With Commercial Production Of Biofeedback Scanner 0 comments
    Jun 25, 2013 3:32 PM | about stocks: BIZM

    Biozoom, a technology development company and creator of the world's first portable, handheld device for real-time biofeedback scanner, has moved the device into commercial production with the first shipment slated to arrive in September.

    "The Biozoom scanner has captured the attention of so many organizations that production has moved from prototype to commercial scale," Biozoom CTO Dr. Wolfgang Kocher stated in the press release. "They will be used to extend our test marketing with key commercial, healthcare and governmental entities."

    The Biozoom scanner non-invasively measures and analyzes biomarkers to understand, manage, and improve the user's health and wellness. With the ability to measure anti-aging factors such as skin moisture and nutritional absorption, the device also has application in the cosmetics industry. The first commercially produced scanners will be used for large-scale studies by cosmetics and consumer goods producers, as well as large employers.

    "… The scanner gives new insight into the overall health and wellbeing of users by measuring antioxidant levels, stress responses and much more. Several large organizations have expressed interest in using the scanner to understand and support the health of their employees," said Dr. Kocher. "By focusing on wellness and disease prevention, they can use Biozoom to help drive down healthcare costs and absenteeism due to preventable illness."

    Biozoom said the prototype units have been validated in clinical trials and have already been implemented in several European institutions.

    "We have reached an exciting milestone," said CEO Hardy Hoheisel. "The first commercially produced units will include all of the patented components and will prove the feasibility of low-cost mass production."

    For more information, visit

    Please see disclaimer on the MissionIR website

    Stocks: BIZM
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.